Prabha Sridevan, the former chairperson of India’s Intellectual Property Appellate Board, says that just as Indian companies must obey American laws when selling their wares in the US, international pharmaceutical companies must similarly comply with Indian laws if they wish to do business in the world’s second most populous market
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Rebecca Newman at Addleshaw Goddard, who live-reported on the seminal dispute, unpicks the trials and tribulations of the case and considers its impact
IP leaders at Brandsmiths and Bird & Bird, who were on opposing sides at the UK Supreme Court in Iconix v Dream Pairs, unpick the landmark case and its ramifications